𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genome-wide search for loss of heterozygosity in Burkitt lymphoma cell lines

✍ Scribed by Hagay Sobol; Athmane Benziane; Fabienne Kerangueven; Luo Yin; Tetsuro Noguchi; Suzanne Pauly; François Eisinger; Michel Longy; Giovanni Romeo; Gilbert Lenoir; Daniel Birnbaum

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
459 KB
Volume
33
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The molecular biological characteristics of Burkitt lymphoma (BL), in addition to the presence of the Epstein‐Barr virus (EBV) in some forms, relies on well‐characterized alterations, such as MYC translocations and TP53 inactivations. To ascertain the number and location of other genome alterations, we used 191 polymorphic markers in a genome‐wide search for loss of heterozygosity (LOH) in 31 Burkitt lymphoma cell lines and their normal counterparts. We were able to distinguish two types of altered allelic patterns: a bona fide LOH profile, indicative of deletion (LOH), and a profile indicative of increased dosage (ID). The former type was most frequent at chromosome arm 17p, most likely indicating TP53 gene inactivation. Increased dosage at 1q was found almost exclusively in non‐EBV cell lines (P < 0.00004) and correlated well with karyotypic abnormalities affecting region 1q21‐25. Our results suggest that a gene important for BL pathogenesis is located in region 1q21‐25 and that the activation of this gene mimics the effects of EBV. © 2002 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Mechanism for induction of hydroxyurea r
Mechanism for induction of hydroxyurea resistance and loss of latent EBV genome in hydroxyurea-treated Burkitt's lymphoma cell line Raji
✍ Ru Jiang; Jian-Ling Zhang; Yukio Satoh; Takeshi Sairenji 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

## Abstract Hydroxyurea (HU), as an inhibitor of ribonucleotide reductase (RR) through interaction with the R2 component, has been used in the treatment of malignancies. Recently, therapeutic strategies in Epstein‐Barr Virus (EBV)‐targeted lymphoma have been reported. In order to study the effect o

Different localization of epstein-barr v
Different localization of epstein-barr virus genome in two subclones of the burkitt lymphoma cell line namalwa
✍ Silvia Gargano; Daniela Caporossi; Giampiero Gualandi; Enrico Calef 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB

The Epstein-Barr virus genome contained in the Burkitt lymphoma line Namalwa was previously localized to the short arm of chromosome I. Analysis of a different subline of the same Namalwa line by means of Southern analysis carried out on genomic D N A , as well as in situ hybridization, showed a loc

Contrasting effects of hydroxyurea on ce
Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs. Burkitt's lymphoma cell lines
✍ Ru Jiang; Mikiko Kanamori; Yukio Satoh; Makoto Fukuda; Kazufumi Ikuta; Masanao M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 1 views

## Abstract Eliminating Epstein‐Barr virus (EBV) genomes from infected cells is an intriguing theoretical strategy in therapy for EBV‐associated malignant diseases. Respective patterns were characterized for hydroxyurea (HU)‐promoted loss of EBV genomes from EBV‐infected epithelioid cell lines deri

Hemizygous deletions in the HLA region a
Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system
✍ Ekaterina S. Jordanova; Sietske A. Riemersma; Katja Philippo; Micheline Giphart- 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

## Abstract Loss of heterozygosity (LOH) is a major mechanism for inactivation of tumor‐suppressor genes and has been observed in various solid tumors and lymphomas. The human leukocyte antigen (HLA) region is located at chromosome band 6p21.3, and loss or alteration of this region may provide tumo